Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy.
Michael ThySaik UrienNaim BouazzaFrantz FoissacInès GanaEmmanuelle BilleAgathe BérangerJulie ToubianaRomain BerthaudFabrice LesageSylvain RenolleauJean-Marc TréluyerSihem BenaboudMehdi OualhaPublished in: Clinical pharmacokinetics (2022)
Meropenem exposure in critically ill children receiving continuous renal replacement therapy needs dosing adjustments to the minimum inhibitory concentration that take into account body weight and the continuous renal replacement therapy effluent flow rate.